Amicogen, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 1,461.56 million compared to KRW 811.56 million a year ago. Net income was KRW 1,873.97 million compared to net loss of KRW 8,710.05 million a year ago.

Basic earnings per share from continuing operations was KRW 47.5 compared to basic loss per share from continuing operations of KRW 220.5 a year ago. Diluted earnings per share from continuing operations was KRW 47.5 compared to diluted loss per share from continuing operations of KRW 220.5 a year ago. Basic earnings per share was KRW 47.5 compared to basic loss per share of KRW 220.5 a year ago.